9.12
전일 마감가:
$9.12
열려 있는:
$9.15
하루 거래량:
528.44K
Relative Volume:
0.85
시가총액:
$370.58M
수익:
$324.01M
순이익/손실:
$-192.37M
주가수익비율:
-1.9079
EPS:
-4.78
순현금흐름:
$-23.46M
1주 성능:
-0.11%
1개월 성능:
-6.75%
6개월 성능:
-26.81%
1년 성능:
+19.06%
Angiodynamic Inc Stock (ANGO) Company Profile
명칭
Angiodynamic Inc
전화
(518) 798-1215
주소
14 PLAZA DRIVE, LATHAM
ANGO을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
ANGO
Angiodynamic Inc
|
9.12 | 370.58M | 324.01M | -192.37M | -23.46M | -4.78 |
![]()
ISRG
Intuitive Surgical Inc
|
496.87 | 177.07B | 9.15B | 2.61B | 1.99B | 7.17 |
![]()
BDX
Becton Dickinson Co
|
182.38 | 52.43B | 20.87B | 1.50B | 2.59B | 5.24 |
![]()
ALC
Alcon Inc
|
91.44 | 44.59B | 9.93B | 1.12B | 1.58B | 2.25 |
![]()
RMD
Resmed Inc
|
277.70 | 40.10B | 5.02B | 1.31B | 1.56B | 8.91 |
![]()
WST
West Pharmaceutical Services Inc
|
252.94 | 18.53B | 2.90B | 467.20M | 306.90M | 6.37 |
Angiodynamic Inc Stock (ANGO) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-07-16 | 개시 | Lake Street | Buy |
2024-04-05 | 업그레이드 | Oppenheimer | Perform → Outperform |
2023-09-25 | 개시 | H.C. Wainwright | Buy |
2023-04-17 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
2021-10-15 | 업그레이드 | Canaccord Genuity | Hold → Buy |
2021-08-20 | 개시 | Oppenheimer | Perform |
2020-11-25 | 업그레이드 | Raymond James | Mkt Perform → Strong Buy |
2020-04-08 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
2019-04-01 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
2018-04-03 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
2018-01-05 | 다운그레이드 | Craig Hallum | Buy → Hold |
2017-04-07 | 재확인 | Cantor Fitzgerald | Overweight |
2017-03-30 | 다운그레이드 | KeyBanc Capital Mkts | Overweight → Sector Weight |
2017-02-08 | 개시 | Barclays | Equal Weight |
2016-11-04 | 개시 | Cantor Fitzgerald | Buy |
2016-04-08 | 재개 | Piper Jaffray | Neutral |
2016-01-08 | 재확인 | Canaccord Genuity | Buy |
2015-11-10 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
2015-07-24 | 개시 | KeyBanc Capital Mkts | Overweight |
2014-06-19 | 업그레이드 | Canaccord Genuity | Hold → Buy |
2012-10-09 | 재확인 | Canaccord Genuity | Hold |
2012-06-25 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
2011-07-15 | 업그레이드 | Canaccord Genuity | Hold → Buy |
2011-07-15 | 업그레이드 | Stifel Nicolaus | Hold → Buy |
2011-06-14 | 다운그레이드 | Wedbush | Neutral → Underperform |
2010-09-08 | 재확인 | Wedbush | Neutral |
모두보기
Angiodynamic Inc 주식(ANGO)의 최신 뉴스
AngioDynamics Inc. stock retracement – recovery analysisPre-Market Stock Movement Summary and Review - Newser
What institutional investors are buying AngioDynamics Inc. stockMaximize your portfolio’s earning power - jammulinksnews.com
Is AngioDynamics Inc. stock overvalued or undervaluedPost Market Outlook For Every Investor - jammulinksnews.com
Building trade automation scripts for AngioDynamics Inc.Free Community Shared Smart Money Signals - Newser
How strong is AngioDynamics Inc. company’s balance sheetUnlock powerful investment tools for free - jammulinksnews.com
Is AngioDynamics Inc. a growth stock or a value stockUnprecedented profit potential - jammulinksnews.com
When is AngioDynamics Inc. stock expected to show significant growthMaximize returns with data-driven strategies - jammulinksnews.com
What is AngioDynamics Inc. company’s growth strategyOver 200% growth - jammulinksnews.com
How AngioDynamics Inc. stock performs during market volatilityFree High Yield Stocks With Buy Confirmation - Newser
Why AngioDynamics Inc. stock attracts strong analyst attentionEntry Level Low Risk Picks - Newser
New York State Common Retirement Fund Has $513,000 Stock Holdings in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
What drives AngioDynamics Inc. stock priceUnstoppable profit momentum - PrintWeekIndia
Is AngioDynamics Inc. a good long term investmentOutstanding capital returns - PrintWeekIndia
What analysts say about AngioDynamics Inc. stockFree AI-Backed Trading Signals - Autocar Professional
AngioDynamics Inc. Stock Analysis and ForecastMarket-beating performance - Autocar Professional
Principal Financial Group Inc. Raises Stock Position in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
AngioDynamics (NASDAQ:ANGO) Given a $17.00 Price Target at Canaccord Genuity Group - Defense World
HC Wainwright Reiterates Buy Rating for AngioDynamics (NASDAQ:ANGO) - Defense World
AngioDynamics Reports Strong Growth in Fiscal 2025 - The Globe and Mail
AngioDynamics, Inc. (NASDAQ:ANGO) EBITDA Improves - FXDailyReport.Com
AngioDynamics, Inc. (NASDAQ:ANGO) Q4 2025 Earnings Call Transcript - Insider Monkey
AngioDynamics Inc (ANGO) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid Tariff ... - Yahoo Finance
AngioDynamics Reports Strong Growth Amid Challenges - TipRanks
AngioDynamics, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:ANGO) - Seeking Alpha
AngioDynamics Inc reports results for the quarter ended May 31Earnings Summary - TradingView
Transcript : AngioDynamics, Inc., Q4 2025 Earnings Call, Jul 15, 2025 - MarketScreener
AngioDynamics Delivers Strong Q4 As Med Tech Sales Jump - Finimize
Angiodynamic Inc (ANGO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):